Compare GRWG & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRWG | XTNT |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.2M | 86.2M |
| IPO Year | N/A | N/A |
| Metric | GRWG | XTNT |
|---|---|---|
| Price | $1.28 | $0.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $2.50 | $1.50 |
| AVG Volume (30 Days) | ★ 317.2K | 187.7K |
| Earning Date | 03-12-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $161,356,000.00 | $133,083,000.00 |
| Revenue This Year | N/A | $15.08 |
| Revenue Next Year | $4.00 | N/A |
| P/E Ratio | ★ N/A | $53.76 |
| Revenue Growth | N/A | ★ 16.88 |
| 52 Week Low | $0.82 | $0.34 |
| 52 Week High | $2.40 | $0.95 |
| Indicator | GRWG | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 30.48 | 35.32 |
| Support Level | $1.42 | $0.60 |
| Resistance Level | $1.40 | $0.62 |
| Average True Range (ATR) | 0.08 | 0.04 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 5.33 | 13.61 |
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.